AstraZeneca (STU:ZEGA) Other Current Liabilities: €698 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:ZEGA AstraZeneca PLC STU:ZEGA
88 GF Score
Price €78.00
GF Value €82.73
! 1 Warning Sign
View Full Analysis

What is AstraZeneca Other Current Liabilities?

AstraZeneca STU:ZEGA +1.30% 88 Other Current Liabilities is €698 Mil as of Mar. 2026. GuruFocus rates STU:ZEGA with a GF Score™ of 88/100 and a GF Value™ of €82.73. The stock has 1 warning sign investors should review.

AstraZeneca's other current liabilities for the quarter that ended in Mar. 2026 was €698 Mil.

AstraZeneca's quarterly other current liabilities increased from Sep. 2025 (€1,027 Mil) to Dec. 2025 (€17,168 Mil) but then declined from Dec. 2025 (€17,168 Mil) to Mar. 2026 (€698 Mil).

AstraZeneca's annual other current liabilities increased from Dec. 2023 (€16,262 Mil) to Dec. 2024 (€16,534 Mil) and increased from Dec. 2024 (€16,534 Mil) to Dec. 2025 (€17,168 Mil).

AstraZeneca Other Current Liabilities Related Terms

AstraZeneca Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for AstraZeneca's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AstraZeneca Other Current Liabilities Chart

AstraZeneca Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13,218.36 14,159.06 16,262.08 16,533.92 17,167.96

AstraZeneca Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,408.78 1,099.36 1,026.66 17,167.96 698.06
STU:ZEGA
88GF Score
AstraZeneca PLC STU:ZEGA
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AstraZeneca Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €698 Mil mean?
AstraZeneca (STU:ZEGA) has a Other Current Liabilities of €698 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on AstraZeneca.
Is AstraZeneca's Other Current Liabilities too high?
AstraZeneca's current Other Current Liabilities is €698 Mil. Overall, AstraZeneca has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does AstraZeneca's Other Current Liabilities compare to LLY and JNJ?
AstraZeneca's Other Current Liabilities of €698 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on AstraZeneca. AstraZeneca's current Other Current Liabilities is €698 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AstraZeneca stock overvalued right now?
AstraZeneca (STU:ZEGA) has a current Other Current Liabilities of €698 Mil. The stock's GF Value™ is €82.73, compared to a current price of €78.00 — trading 5.7% below its estimated fair value. The current Other Current Liabilities is €698 Mil. AstraZeneca's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For AstraZeneca (STU:ZEGA), the current Other Current Liabilities is €698 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AstraZeneca (STU:ZEGA) Overvalued in 2026?

Based on GuruFocus' analysis, AstraZeneca stock appears to be undervalued. The current stock price of €78.00 is trading 5.7% below its estimated GF Value™ of €82.73.

Key valuation signals for STU:ZEGA:

  • Other Current Liabilities: €698 Mil
  • GF Value™: €82.73 vs. price of €78.00 (5.7% below fair value)
  • GF Score™: 88/100 with 1 warning sign

No single metric tells the full story. See the STU:ZEGA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AstraZeneca Business Description

Address 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
88GF Score

Get the complete analysis for STU:ZEGA

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€78.00
Price
€82.73
GF Value